How to Talk to Your Doctor About GLP-1 Medications and Addiction

You've read the research. Semaglutide associated with reduced alcohol use, lower opioid overdose risk, fewer smoking-related healthcare visits, decreased cannabis use disorder. The data is compelling. But there's a gap between reading a study and sitting in a doctor's office trying to explain why you think a diabetes medication might help with your drinking.

This guide bridges that gap. Whether you're approaching your primary care doctor, a psychiatrist, an addiction specialist, or a telehealth provider, here's how to frame the conversation productively.

Before the Appointment

Know What You're Actually Asking For

Here's the critical distinction: you are not asking your doctor to prescribe a GLP-1 medication for addiction. No GLP-1 medication is FDA-approved for any substance use disorder. What you're doing is asking whether a GLP-1 medication might be appropriate for its approved indications — weight management or type 2 diabetes — while openly discussing the emerging research on craving reduction as an additional consideration in the treatment decision.

This framing matters. It keeps the conversation within approved medical guidelines while allowing space to discuss the broader evidence.

Check Your Eligibility

GLP-1 medications are currently FDA-approved for:

• Type 2 diabetes (semaglutide as Ozempic, tirzepatide as Mounjaro)
• Chronic weight management in adults with BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (semaglutide as Wegovy, tirzepatide as Zepbound)

If you meet either criterion, the conversation is straightforward — you're discussing an approved medication for an approved indication. If you don't meet either criterion, the off-label prescribing conversation becomes more complex and provider-dependent.

Prepare Your Health Snapshot

• Your current BMI (calculators are free online — be honest)
• Any weight-related conditions: high blood pressure, high cholesterol, sleep apnea, pre-diabetes, joint pain
• Your current and past substance use — timing, frequency, any quit attempts
• Current medications, especially anything that affects blood sugar
• Family history of diabetes, obesity, or substance use disorders
• What you've already tried for both weight management and substance reduction

What to Actually Say

Opening the Conversation

Lead with your approved-indication reason. Then introduce the research as additional context.

Questions to Ask Your Doctor

Your doctor may or may not be familiar with the addiction research. Either way, these questions help drive a productive conversation:

1. "Am I a candidate for a GLP-1 medication based on my BMI and health history?" — Establishes the approved-indication foundation first.
2. "Are you familiar with the recent studies on GLP-1 medications and substance use disorders?" — Gauges their awareness without being confrontational. If they're not, you can offer to share the citations (listed at the bottom of this article).
3. "Would this interact with any of my current medications?" — Especially important if you're on naltrexone, buprenorphine, methadone, or other addiction medications.
4. "What would the monitoring plan look like?" — Good doctors appreciate patients who ask about follow-up, not just prescriptions.
5. "If you're not comfortable prescribing this, can you refer me to someone who specializes in both weight management and substance use?" — A graceful exit if your provider says no.

What to Expect From Your Doctor

They might also say "let me look into this" — which is a perfectly reasonable response. The research is legitimate (published in top-tier journals by NIH-affiliated researchers), but it's still evolving. A cautious doctor who does their homework before prescribing is a good doctor.

A Note on Honesty

It might be tempting to downplay the substance use aspect and just ask for a weight loss medication. Don't. Your doctor needs the full picture to prescribe safely. GLP-1 medications affect appetite, metabolism, gastric motility, and potentially neurotransmitter systems — interactions with alcohol, other medications, and underlying conditions all matter.

The research isn't something to hide. It's published in the world's most respected medical journals. Bringing it up shows you're informed and engaged in your own healthcare. Most doctors welcome that.

If You're Not Ready for a Doctor

Not everyone is ready for a clinical conversation. If you're still exploring, here are some lower-barrier next steps:

• Read the source studies — links are below. Understanding the data yourself puts you in a stronger position when you do talk to a provider.
• Talk to SAMHSA — their helpline (1-800-662-4357) is free, confidential, and available 24/7. They can help you find local treatment resources regardless of where you are in the process.
• Explore telehealth — online providers specializing in GLP-1 prescribing can often be more accessible than traditional in-person appointments, especially if you live in a rural area or don't have an established primary care relationship.